chr1-63367903-G-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_013339.4(ALG6):​c.-208+216G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0243 in 152,310 control chromosomes in the GnomAD database, including 117 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.024 ( 117 hom., cov: 32)

Consequence

ALG6
NM_013339.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.570

Publications

0 publications found
Variant links:
Genes affected
ALG6 (HGNC:23157): (ALG6 alpha-1,3-glucosyltransferase) This gene encodes a member of the ALG6/ALG8 glucosyltransferase family. The encoded protein catalyzes the addition of the first glucose residue to the growing lipid-linked oligosaccharide precursor of N-linked glycosylation. Mutations in this gene are associated with congenital disorders of glycosylation type Ic. [provided by RefSeq, Jul 2008]
ITGB3BP (HGNC:6157): (integrin subunit beta 3 binding protein) This gene encodes a transcriptional coregulator that binds to and enhances the activity of members of the nuclear receptor families, thyroid hormone receptors and retinoid X receptors. This protein also acts as a corepressor of NF-kappaB-dependent signaling. This protein induces apoptosis in breast cancer cells through a caspase 2-mediated signaling pathway. This protein is also a component of the centromere-specific histone H3 variant nucleosome associated complex (CENP-NAC) and may be involved in mitotic progression by recruiting the histone H3 variant CENP-A to the centromere. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 1-63367903-G-T is Benign according to our data. Variant chr1-63367903-G-T is described in ClinVar as Benign. ClinVar VariationId is 1242754.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0756 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_013339.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG6
NM_013339.4
MANE Select
c.-208+216G>T
intron
N/ANP_037471.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG6
ENST00000263440.6
TSL:5 MANE Select
c.-208+216G>T
intron
N/AENSP00000263440.5Q9Y672
ALG6
ENST00000948329.1
c.-208+221G>T
intron
N/AENSP00000618388.1
ALG6
ENST00000920026.1
c.-208+216G>T
intron
N/AENSP00000590085.1

Frequencies

GnomAD3 genomes
AF:
0.0242
AC:
3680
AN:
152192
Hom.:
113
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0775
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00661
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0177
Gnomad SAS
AF:
0.0190
Gnomad FIN
AF:
0.0106
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.0229
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0243
AC:
3702
AN:
152310
Hom.:
117
Cov.:
32
AF XY:
0.0244
AC XY:
1817
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0778
AC:
3235
AN:
41560
American (AMR)
AF:
0.00653
AC:
100
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0178
AC:
92
AN:
5174
South Asian (SAS)
AF:
0.0186
AC:
90
AN:
4834
European-Finnish (FIN)
AF:
0.0106
AC:
113
AN:
10618
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000323
AC:
22
AN:
68026
Other (OTH)
AF:
0.0227
AC:
48
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
172
344
515
687
859
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0164
Hom.:
13
Bravo
AF:
0.0255
Asia WGS
AF:
0.0240
AC:
83
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
7.6
DANN
Benign
0.80
PhyloP100
0.57
PromoterAI
0.021
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75502742; hg19: chr1-63833574; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.